US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.82

+0.34801.01%

Volume:14.09K

Turnover:489.40K

Market Cap:96.80M

PE:- -

High:34.92

Open:34.52

Low:34.42

Close:34.47

52wk High:36.84

52wk Low:23.42

Shares:2.78M

Float Shares:2.78M

Volume Ratio:0.80

T/O Rate:0.51%

Dividend:0.26

Dividend Rate:0.74%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Gan&Lee Receives Clinical Trial Approval for GZC8072 Tablet in New Indication

Sino Biopharmaceutical Stock Rises 6.3% in Hong Kong, Outperforms Competitors

ST Renfu Initiation of Phase II Clinical Study for Novel Postoperative Pain Candidate

Clinical Data Readouts Take Center Stage as Chinese Biotech Firms Surge; CSPC Pharma Climbs Over 4% While Huabao's HK Biotech ETF Holds Key Support

Vertex Minerals Seeks Trading Halt Ahead of Capital Raising Plan

Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares

Amgen to Present at Wells Fargo Healthcare Conference Webcast

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-09-02

Regeneron Announces Q3 2026 Dividend of R$ 0.05 Per Unit

OCUMENSION-B Completes Patient Enrollment in Phase III Trial of Dry Eye Treatment

Political and General News Events from September 2

uniQure seeks accelerated approval for Huntington’s gene therapy

Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)

Guangdong Zhongsheng Pharmaceutical (002317.SZ) Secures NMPA Acceptance for Expanded Indication Trial of Onradivir Tablets

Wall Street Analysts Are Bullish on Top Healthcare Picks

What Does Crinetics Pharmaceuticals (CRNX) Delisting Mean After The Takeover Closed?

Simply Wall St.

Betta Pharma's Hong Kong IPO: A Profit Pioneer Faces Patent Cliffs and Pipeline Doubts

FedEx Incheon Gateway Wins IATA CEIV Pharma Certification

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/IBBQ/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.82,"timestamp":1789416000000,"preClose":34.472,"halted":0,"volume":14094,"delay":0,"changeRate":0.01009514968670222,"floatShares":2780001,"shares":2780001,"eps":0,"marketStatus":"Pre-Mkt","change":0.348,"latestTime":"09-15 07:10:23 EDT","open":34.52,"high":34.92,"low":34.42,"amount":489401.81775,"amplitude":0.014505,"askPrice":55.71,"askSize":200,"bidPrice":32.86,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":34.82,"sharesOutstanding":2520001,"nav":34.43989,"aum":95742928.63989,"dividendRate":0.007412,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.82,"preClose":34.82,"latestTime":"19:30 EDT","volume":36,"amount":1244.0123,"timestamp":1789428600873,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8014967633025524,"impliedVol":0.1149,"impliedVolPercentile":0.492},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2780001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8014967633025524,"shares":2780001,"dividePrice":0.2581,"high":34.92,"amplitude":0.014505,"preClose":34.472,"low":34.42,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.82,"eps":0,"divideRate":0.007412,"volume":14094,"delay":0,"ttmEps":0,"open":34.52,"prevYearClose":28.3962,"prevWeekClose":34.472,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":36.05,"twentyDayClose":33.8122,"sixtyDayClose":29.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1108699787","title":"Gan&Lee Receives Clinical Trial Approval for GZC8072 Tablet in New Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=1108699787","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108699787?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:34","pubTimestamp":1788424482,"startTime":"0","endTime":"0","summary":"Gan&Lee Pharmaceuticals (SH: 603087) announced that its wholly-owned subsidiary, Gan&Lee Pharmaceuticals Shandong Co., Ltd., has received the \"Drug Clinical Trial Approval Notice\" from the National...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603087","PSYK","IBBQ","MDTX","BMED","IBBJ","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664482770","title":"Sino Biopharmaceutical Stock Rises 6.3% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664482770","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664482770?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:31","pubTimestamp":1788424260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 6.3% to 5.59 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.4% to 25213.31.Sino Biopharmaceutical Ltd. closed 39% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 4.8% and Amgen Inc. remained unchanged.Trading volume totaled 127.7 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","BK4581","TBXU","LU0109394709.USD","LU0122379950.USD","HK0000165453.HKD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU2468319806.SGD","LU2242652126.USD","LU1571399168.USD","LU2112291526.USD","PBE","LU0320765992.SGD","BK4588","IE00BJJMRZ35.SGD","IBB","BK4566","BK4139","01177","IBBQ","LU1023059063.AUD","BK1515","LU0889565916.HKD","BBH","IE00BZ08YS42.EUR","SG9999001440.SGD","LU0289739699.SGD","LU2089984988.USD","LU1983299246.USD","LU1057294990.SGD","AMGN","LU1061106388.HKD","BK1521","BK1589","BK4534","BK4599","BK1191","IE0009355771.USD","IE0002141913.USD","IE00B4R5TH58.HKD","BK4585","IE00BJT1NW94.SGD","IE00BZ08YR35.GBP","LU2242646821.SGD","IE00B2B36J28.USD","PJP","IE00BZ08YT58.USD","BK4533","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108389066","title":"ST Renfu Initiation of Phase II Clinical Study for Novel Postoperative Pain Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1108389066","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108389066?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:16","pubTimestamp":1788423398,"startTime":"0","endTime":"0","summary":"ST Renfu (600079.SH) announced that its controlled subsidiary, Yichang Renfu Pharmaceutical Co., Ltd. (in which the company holds an 80% stake), has commenced a Phase II clinical trial for its...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0185","BK0070","IBBJ","BMED","IBBQ","BK0188","MDTX","PSYK","600079","BK0096","BK0239","BK0028","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128427781","title":"Clinical Data Readouts Take Center Stage as Chinese Biotech Firms Surge; CSPC Pharma Climbs Over 4% While Huabao's HK Biotech ETF Holds Key Support","url":"https://stock-news.laohu8.com/highlight/detail?id=1128427781","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128427781?lang=en_us&edition=fundamental","pubTime":"2026-09-03 11:00","pubTimestamp":1788404450,"startTime":"0","endTime":"0","summary":"Hong Kong-listed innovative drug stocks continued their upward momentum on September 3rd, with leading biotech names pushing the sector higher. CSPC Pharma and Sino Biopharmaceutical both advanced...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","IE0008368742.USD","FLHK","BK1521","LU1960683339.HKD","LU0315179316.USD","LU0880133367.SGD","01093","HK0000165453.HKD","IE00B031HY20.USD","LU0326950275.SGD","IBBQ","LU1226287792.SGD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","159316","BK1574","LU1951186391.HKD","LU0072913022.USD","BK1161","IE0008369823.USD","06978","LU1226288253.USD","KURE","LU1993786604.SGD","LU2039709279.SGD","LNGR","IE00BZ08YT58.USD","159992","LU0314109678.HKD","LU0140636845.USD","LU0067412154.USD","MEDX","LU0501845795.SGD","LU1226288170.HKD","BK1515","IE00B5MMRT66.SGD","SG9999004220.SGD","LU1328277881.USD","LU1152091754.HKD","LU1807302812.USD","IE00B543WZ88.USD","LU1226287875.USD","LU1813983027.USD","LU1226287529.USD","LU1008478684.HKD","LU1152091168.USD","520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664422868","title":"Vertex Minerals Seeks Trading Halt Ahead of Capital Raising Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2664422868","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664422868?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:44","pubTimestamp":1788392661,"startTime":"0","endTime":"0","summary":"Vertex Minerals Ltd. ( ($AU:VTX) ) has shared an update. Vertex Minerals Ltd, an Australian minerals and resources company listed on the ASX as VTX...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-seeks-trading-halt-ahead-of-capital-raising-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-seeks-trading-halt-ahead-of-capital-raising-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289739699.SGD","BK4532","IE00B2B36J28.USD","GNMX","LU2362541513.USD","LU2362541273.HKD","LU0061475181.USD","PBE","LU0823416689.USD","IBB","IBBQ","IE0009355771.USD","LU0757428866.USD","LU2324357040.USD","TBXU","LU1559883803.SGD","SG9999001176.SGD","LU2237438978.USD","LU0079474960.USD","LU0889565916.HKD","MTX","IE00BFTCPJ56.SGD","LU1585245621.USD","LU1674673691.USD","SG9999013999.USD","VERX","IE00BZ9MQY76.HKD","LU0256863811.USD","IE00B19Z9P08.USD","LU2417539215.USD","LU2362540622.SGD","LU1430594728.SGD","BIB","IE00B19Z9Z06.USD","LU2236285917.USD","LU0058720904.USD","IDNA","BBH","LU0320765992.SGD","IE00B19Z3B42.SGD","LU0432979614.USD","LU2456880835.USD","IE0002141913.USD","VRTX","LU0109394709.USD","BK4023","IE00B4R5TH58.HKD","SGXZ57979304.SGD","BK4585","SG9999001176.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664499688","title":"Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2664499688","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664499688?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:13","pubTimestamp":1788380002,"startTime":"0","endTime":"0","summary":"Gilead CEO Daniel O'Day disposes of USD 2.23 million in common sharesGilead Sciences Chairman and CEO Daniel Patrick O’Day sold 14,000 common shares on Sep. 1, 2026.Sales priced at about $147.51 to $1","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL5HTC5L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead CEO Daniel O'Day Disposes of USD 2.23 Million in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","LU0965509010.AUD","TBXU","BBH","BIB","LU1674673691.USD","LU0823416689.USD","BK4568","IBBQ","LU0114720955.EUR","LU0320765992.SGD","IE00B7SZLL34.SGD","LU1934455277.USD","LU2087621335.USD","LU1061106388.HKD","LU2357627491.SGD","BK4585","LU0861579265.USD","BK4583","SG9999015952.SGD","LU0882574055.USD","IE0002270589.USD","SG9999015978.USD","LU0109394709.USD","LU1066053197.SGD","LU0289739699.SGD","LU0965508806.USD","LU2324357040.USD","LU0122379950.USD","IBB","LU1585245621.USD","IE00B19Z3581.USD","LU0965509101.SGD","LU0859254822.USD","LU0889565916.HKD","LU1023059063.AUD","LU1057294990.SGD","LU1571399168.USD","LU1839511570.USD","TMED","IE00BZ1G4Q59.USD","LU1066051498.USD","GILD","IE00BSNM7G36.USD","LU1934455194.USD","LU0965509283.SGD","BMED","IE00B19Z3B42.SGD","BK4578","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664096846","title":"Amgen to Present at Wells Fargo Healthcare Conference Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2664096846","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664096846?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:01","pubTimestamp":1788379299,"startTime":"0","endTime":"0","summary":"Amgen to present at Wells Fargo Healthcare Conference webcastAmgen will present at the 2026 Wells Fargo Healthcare Conference on Sept. 10, 2026 at 11:00 a.m. ET.Speakers include CFO Thomas Dittrich, C","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL9RK355:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","BK4588","TBXU","BK4581","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0868494617.USD","BK4566","IBBQ","LU0109394709.USD","IE0002141913.USD","LU1057294990.SGD","LU2242652126.USD","AMGN","PJP","LU2468319806.SGD","IBB","LU2089984988.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","LU2112291526.USD","BK4533","BK4139","PBE","BK4599","LU0058720904.USD","LU1983299246.USD","LU2242646821.SGD","BIB","LU0320765992.SGD","BK4534","LU0289739699.SGD","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU0889565916.HKD","BK4585","LU1571399168.USD","LU0122379950.USD","LU1061106388.HKD","IE00B2B36J28.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664784686","title":"NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-09-02","url":"https://stock-news.laohu8.com/highlight/detail?id=2664784686","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664784686?lang=en_us&edition=fundamental","pubTime":"2026-09-03 02:45","pubTimestamp":1788374714,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EDT on 2026-09-02Nasdaq 100.NDXTop PerformersPercent ChangeAlnylam Pharmaceuticals, Inc.ALNY.OQ+7.9%Regeneron Pharmaceuticals, Inc.REGN.OQ+3.5%PayPal Holdings, Inc.PYPL.OQ+3.4%NVIDIA CorporationNVDA.OQ+3.3%Keurig Dr Pepper IncKDP.OQ+3.3%Bottom PerformersPercent ChangePalo Alto Networks, Inc.PANW.OQ-10.6%Datadog IncDDOG.OQ-6.6%CrowdStrike Holdings, Inc.CRWD.OQ-6.5%Palantir Technologies Inc.PLTR.OQ-6.3%Fortinet, Inc.FTNT.OQ-5.4%The Nasdaq 100.NDXgained 12.41 points, or 0.04%, to 29,090.11 and recorded 2 new highs and no new lows. 49 stocks rose and 51 fell as declining issues outnumbered advancers by about a 1-to-1 ratio.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL8N44U25Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["2NVD.UK","LU1983260115.SGD","LU3102509885.SGD","LU2931357623.SGD","IE00B4YYXB79.USD","NJUL","LU2095319765.USD","LU2362540622.SGD","LU1935042488.USD","IE00B1BXHZ80.USD","LU1935043536.SGD","LU0472753341.HKD","SPLTRmain","LU0342679015.USD","LU1868837300.USD","HK0000914686.HKD","LU2236285917.USD","SGXZ99366536.SGD","LU1721428933.USD","IE00B19Z9Z06.USD","PYPG","LU0795875169.SGD","SG9999014559.SGD","LU0082616367.USD","NVDQ","LU2023250330.USD","LU2468319806.SGD","SHLD","LU0354030438.USD","LU1035775433.USD","LU0256863902.USD","LU2403377893.USD","PALD","LU1934455863.HKD","IE00BK4W5M84.HKD","LU0787776722.HKD","LU1868836757.USD","QDEC","LU1861127337.USD","LU1496350171.SGD","LU0130102774.USD","SG9999015952.SGD","LU2471134952.CNY","LU0965509283.SGD","SG9999015341.SGD","LU2028103732.USD","ROM","LU0289739343.SGD","LU1914381329.SGD","LU0786609619.USD","HK0000914660.USD","LU2552382132.HKD","BK4547","BK4598","LU1003077747.HKD","FAI","IE00BJTD4V19.USD","LU2279689827.SGD","ARTY","LU2286300806.USD","02834","LU1861558580.USD","ESLG","SG9999015358.SGD","LU1551013425.SGD","LU2023250504.SGD","LU2430703251.USD","LU0724617625.USD","LU0708994859.HKD","LU1674673691.USD","NVII","LU1169589451.USD","LU0211328371.USD","LU2077746001.SGD","LU2458330169.SGD","LU1815333072.USD","LU2954938101.SGD","PSWD","JGRO","LU1244550577.SGD","LU2491050154.USD","BK4524","LU2322448957.HKD","LU2746668974.SGD","IE00BKDWB100.SGD","PYPU","LU2347655073.USD","LU1127390331.HKD","SGXZ23171101.USD","LU1979441026.SGD","IE000ITXATA3.USD","LU0320765059.SGD","LU0882574055.USD","HAKY","LU0943347566.SGD","LU0345770993.USD","LU0310800379.SGD","IE0004086264.USD","LU1861217088.USD","REGN","LU1668664300.SGD","SPTE","HK0000304805.HKD","LU2047632596.USD","NVD","NVDG","BK4614","LU2106854487.HKD","SHOC","CRWC","LU2360106780.USD","LU1116320737.USD","LU1718418525.SGD","LU0158827781.USD","LU1153585028.USD","IE0034235303.USD","LU0353189680.USD","SG9999015945.SGD","LU0225283273.USD","SGXZ80539844.SGD","LU0672654240.SGD","LU0882574139.USD","LU1496350502.SGD","LU1868837136.USD","QQQ","LU0215105999.USD","NVD2.UK","PBE","BK4177","ESUM","LU0211327993.USD","LU2456880835.USD","LU0345769128.USD","GPIQ","LU0348723411.USD","IE000KEQY171.SGD","LU0868494708.USD","LU0788109477.HKD","BK4579","LU1066051811.HKD","LU1935042215.USD","LU1923622614.USD","LU2326559502.SGD","LU0683600562.USD","LU0395794307.EUR","LU2213496289.HKD","IE0004445239.USD","LU0964807845.USD","IE00BMPRXN33.USD","LU2237438978.USD","NVDW","TQQY","LU0661504455.SGD","LU0080751232.USD","LU0234570918.USD","IE00B775H168.HKD","SG9999015986.USD","LU0170899867.USD","LU2750360997.AUD","SPAM","LU2294711713.HKD","HK0000819398.USD","SG9999018857.SGD","IE00BK4W5L77.USD","LU1064131342.USD","BK4588","IE00BJLML261.HKD","LU0889565916.HKD","LU1791807156.HKD","PLTI",".HXC","LU0251132253.USD","SGXZ51526630.SGD","IE000YTNTUN2.SGD","TRFK","LU0494093205.USD","BK4505","BK4551","IE00B5TLWC47.USD","LU0109394709.USD","LU1861215975.USD","USXF","GNMX","LU0234572021.USD","LU1242518931.SGD","IE000W1ABFV2.USD","LU0107464264.USD","IETC","LU2999663052.SGD","LU1989764748.USD","LU1623119135.USD","09388","IE0034235295.USD","LU0006306889.USD","LU1861220207.SGD","LU2125909247.SGD","LU1880398554.USD","SG9999014575.USD","LU2089984988.USD","LU2242649171.HKD","03455","LU2237443549.SGD","LU0077335932.USD","LU2322448791.USD","SG9999015978.USD","LU0545039389.USD","LU0056508442.USD","SG9999014880.SGD","09086","LU1732799900.SGD","07388","LU2168564149.EUR","CHAT","LU2487616109.SGD","LU2211815571.USD","IE00B3S45H60.SGD","LU0187121727.USD","IE00BDRTCR15.USD","LU0347712357.USD","LU1066053197.SGD","LU0820561909.HKD","BK4585","PLT","LU0557290698.USD","IE00BJJMRY28.SGD","DIPS","LU1852331112.SGD","IE00B3SWFQ91.USD","LU2087621335.USD","LU2756315318.SGD","LU2592432038.USD","LU1674673428.USD","LU1400636574.HKD","LU2168564065.EUR","BK4533","CLSE","LU0057025933.USD","WCBR","LU2210149790.SGD","LU2491049909.HKD","GAMR","LU0823416689.USD","IE00BHPRN162.USD","LU0265550946.USD","LU0265550359.USD","IE00B19Z8W00.USD","LU2250418816.HKD","LU0689472784.USD","IE00BDCRKT87.USD","LU1548497426.USD","NVDL","LU0648001328.SGD","LU0175139822.USD","LU0133085943.USD","LU0345768740.USD","LU1670756490.USD","LU1992135472.HKD","BK4587","LU2125154778.USD","QQQM","LU1037948897.HKD","XLK","IE0034235188.USD","LU0689626769.HKD","LU2264538146.SGD","PLYY","LU0476273544.USD","NVIW.SI","LU1280957306.USD","BK4566","LU0889565833.HKD","BK4141","IE00BD6J9T35.USD","LU0130517989.USD","LU2290526834.HKD","LU0276348264.USD","LU2265009873.SGD","LU1934455194.USD","LU2420271590.USD","LU1642822529.SGD","LU2360107671.USD","LU1202635105.USD","LU2247934214.USD","LU1435385759.SGD","LU2092937148.SGD","LU0965509010.AUD","LU2602419157.SGD","IGV","LU0949170772.SGD","LU2381873111.SGD","LU0114720955.EUR","TTEQ","LU2413666699.HKD","LU1551013342.USD","09834","LU0323240290.USD","LU0069063385.USD","CRWD","SG9999014914.USD","LU2417539215.USD","LU0256863811.USD","LU1267930573.SGD","IHAK","LU2896262040.SGD","SMHX","BK4561","TBXU","LU0354030511.USD","LU0823434740.USD","LU1934455277.USD","LU1429558221.USD","LU0198837287.USD","LU1400636657.SGD","NVDA","PLTG","BK4535","SG9999004303.SGD","SG9999002232.USD","LU2237443622.USD","BK4529","IE00BKPKM429.USD","IE00BZ1G4Q59.USD","BK4097","SOXY","PYPY","LU0124676726.USD","LU1645745479.HKD","LU2089284900.SGD","LU2100268510.USD","LU2552382215.SGD","IE00B7KXQ091.USD","LU0203202063.USD","LU1868836914.USD","LU1989772840.SGD","SMH","BK4560","IE00B4JS1V06.HKD","NVDS.UK","IE0001KFT4U8.USD","LU2361044865.SGD","LU2065171402.SGD","LU0048584097.USD","LU1989763427.SGD","LU1778281490.HKD","SGXZ81514606.USD","LU2065170008.USD","PLTZ","LU2552382058.USD","LU0061475181.USD","SOXQ","FTNT","LU0642271901.SGD","LU0157215616.USD","LU2237957902.USD","LU1923622291.USD","BK4550","SG9999001424.SGD","LU0203201768.USD","BK4528","LU2168563687.JPY","LU0861579265.USD","BK4612","IPAY","LU2097344357.USD","LU1951200564.SGD","LU0174119429.USD","LU1720051017.SGD","LU2063271972.USD","LU1084165304.USD","NULC","LU0444971666.USD","IE00BJTD4N35.SGD","LU0238689110.USD","LU0210533765.USD","LU1821325948.USD","LU2746668461.USD","HK0000306685.HKD","LU2355687059.USD","TQQQ","METV","NVDU","BK4532","LU0345770308.USD","LU0081259029.USD","LU1861559042.SGD","LU1935042991.SGD","09788","LU0823434583.USD","LU1145028129.USD","LU0308772762.SGD","LU2272731600.USD","LU0143551892.USD","LU0323591593.USD","WISE","LU0345768153.USD","LU1169590202.USD","LU2347655156.SGD","LU2433249047.HKD","LU2191332357.HKD","LU2462591350.SGD","LU0553294199.USD","LU1791710582.SGD","SOXX","LU0058720904.USD","SNPE","IE00BZ9MQY76.HKD","TTXU","IE00BN29S564.USD","PLTW","LU2065169927.USD","DOGD","SG9999017495.SGD","CMAG","LU0708995401.HKD","LU2462591277.SGD","NVD3.UK","LU0823414551.USD","LU2637965513.SGD","LU0096364046.USD","LU2271345857.HKD","LU1633808545.USD","HK0000306701.USD","07266","LU2506951792.HKD","07522","LU0289739699.SGD","LU2237443895.HKD","CHPX","LU1244550494.USD","LU0053666078.USD","LU1119994496.HKD","BK4567","EFIV","AGOX","LU1629891620.HKD","IE00BFSS8Q28.SGD","LU0823414478.USD","LU2462157665.USD","NOCT","LU1839511570.USD","PLTU","LU1267930490.SGD","LU1069344957.HKD","PALU","NAPR","LU1814569148.SGD","QMAR","IE00B3M56506.USD","LU1366192091.USD","IE00BMPRXR70.SGD","LU0138981039.USD","LU2125909593.SGD","LU0061474960.USD","LU2054465674.USD","SG9999014906.USD","IE00B894F039.SGD","LU1037948541.HKD","LU2125154935.USD","LU0738911758.USD","IE00BJJMRX11.SGD","LU2357305700.SGD","BBH","3NVD.UK","HK0000304797.USD","LU0079474960.USD","LU1988902786.USD","PANW","QQQX","VT","IE0005OL40V9.USD","LU2237443978.SGD","LU2210150020.SGD","BK4605","LU0097036916.USD","LU1951198990.SGD","LU0029864427.USD","LFGY","BK4139","LU1261432733.SGD","LU0072462426.USD","LU2133065610.SGD","LU0345769631.USD","BK4227","AIPI","ALNY","TEK","LU2125909916.SGD","LU1571399168.USD","CLOD","ANV","THMR","LU0912757837.SGD","LU1868836591.USD","NJAN","GUNZ","LU2083900584.USD","NVDX","VGT","WCLD","SNVD.UK","LU1400636491.USD","IE00BYXW3230.USD","LU0980610538.SGD","FTEC","LU0210536198.USD","LU1699723380.USD","BREW","LU0127658192.USD","LU1880398471.USD","LU1989764664.SGD","LU0109392836.USD","LU0070217475.USD","LU1804176565.USD","SGXZ31699556.SGD","FDTX","LU0640476718.USD","LU1242518857.USD","LU2237443382.USD","LU0528227936.USD","LU2505996509.AUD","PLTL","SQQQ","LU2092627202.USD","LU1917777945.USD","LU1316542783.SGD","IE0008368304.USD","IE00B19Z9505.USD","STBQ","AIFD","LU1712237335.SGD","LU2357125470.USD","IXN","NVDY","IE00BQXX3F31.USD","LU2430703178.SGD","LU2108987350.USD","PLTY","IE0004445015.USD","LU1366333091.USD","NVDB","LU0158827948.USD","SG9999002224.SGD","LU0726765562.USD","LU0106261372.USD","LU1035773651.USD","LU2361044949.HKD","LU2360032135.SGD","LU0957808578.USD","QLD","LU0353189763.USD","LU1323610961.USD","BK4527","IBB","LU2125909759.SGD","CIBR","LU0942090050.USD","LU1201861249.SGD","LU0011850046.USD","DAT","LU0094547139.USD","LU1232071149.USD","03086","LU0820561818.USD","LU1066051225.USD","LU2362541273.HKD","ILDR","SG9999000418.SGD","LU0128525929.USD","LU2065171311.SGD","LU2491050071.SGD","LU1974910355.USD","IE00BWXC8680.SGD","BK4613","ABFL","LU2361045086.USD","IE00B1XK9C88.USD","07568","PLTD","SG9999018865.SGD","LU0109391861.USD","LU2087625088.SGD","PLTR","HK0000532082.HKD","PYPL","TYLG","LU0979878070.USD","BK4503","IE000Q6AESB8.SGD","LU1989772923.USD","CNEQ","LU1923623000.USD","LU2249611893.SGD","LU0466842654.USD","BK4554","BK4534","LU2362541513.USD","NVYY","BUG","LU0957791311.USD","LU2168564222.USD","LU0477156953.USD","EYES","LU2463028550.USD","LU2756315664.SGD","IE00BQXX3D17.EUR","CLOU","LU0444973449.USD","LU1720051108.HKD","LU2148611432.USD","LU2168564495.EUR","LU1144417596.USD","LU2471134879.HKD","LU2097344431.USD","LU1691799644.USD","LU2471134523.USD","LU2471134796.USD","SNVDAmain","PANG","LU2111349929.HKD","LU0289960550.SGD","IE0009356076.USD","PLOO","LU1791710400.SGD","LU2413666426.HKD","NDX","LU1066051498.USD","LU2473716301.USD","LU2461242641.AUD","LU2750360641.GBP","LU0795875086.SGD","LU0985320562.USD","IE00BKVL7J92.USD","IE00BQXX3C00.GBP","03034","LU1815336760.USD","LU2860962120.EUR","PSQ","LU2458330243.SGD","NVDD","LU2272731782.SGD","BK4608","LU0965509101.SGD","IE0009G5SDU7.USD","LU2089283258.USD","LU0289961442.SGD","LU0320765992.SGD","IE0004091025.USD","BK4106","LU0210528500.USD","BK4548","LU0965508806.USD","GB00BDT5M118.USD","LU2394011477.USD","QID","IE00B19Z8X17.USD","NVDO","LU0823421416.USD","LU2237443465.HKD","BK4581","HK0000320264.USD","LU0719512351.SGD","USD","IE00B775SV38.USD","IBBQ","LU0154236417.USD","LU0274383776.USD","LU0310799852.SGD","LU2244417387.USD","LU2272731865.HKD",".IXIC","HK0000320223.HKD","BK4549","IE00B5949003.HKD","LU2430703095.HKD","IE00B19Z9P08.USD","07261","BK4543","LU1267930730.SGD","LU0323239441.USD","IE00BZ199S13.USD","CRWL","LU2360107168.USD","PTIR","LU1935043023.USD","07788","LU0820562030.AUD","LU1732800096.USD","LU1244550221.USD","LU1069347547.HKD","LU1989763690.USD","LU2543165471.USD","LU0316494557.USD","LU1861220033.SGD","LU2505996681.GBP","NVDS","PLTA","LU1992135399.USD","LU1116320901.HKD","SG9999014898.SGD","DDOG","LU2242650005.HKD","LU0417517546.SGD","LU2023251221.USD","LU0823421333.USD","BK4592","IE0003U64NQ7.SGD","LU0390134368.USD","LU0061474705.USD","LU2452424414.USD","LU0266013472.USD","BK4607","LU0267386448.USD","BK4023","KDP","IE00BFSS7M15.SGD","LU1803068979.SGD","IE00BMPRXQ63.HKD","LU0096362180.USD","LU2237957811.SGD","SG9999014567.USD","LU2023250843.SGD","FINX","LU0868494617.USD","LU2089985449.USD","SG9999014542.SGD","LU0106831901.USD","LU0511384066.AUD","NVC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664281843","title":"Regeneron Announces Q3 2026 Dividend of R$ 0.05 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2664281843","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664281843?lang=en_us&edition=fundamental","pubTime":"2026-09-03 01:18","pubTimestamp":1788369530,"startTime":"0","endTime":"0","summary":"Regeneron announces Q3 2026 dividend of R$ 0.05 per unitRegeneron declared a 3Q 2026 dividend of R$ 0.05 per unit.Payment is scheduled for Sept. 4, 2026.Last day to trade with entitlement is Aug. 14, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLbMY9NC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362540622.SGD","BK4588","LU1917777945.USD","IBBQ","LU0320765992.SGD","LU1974910355.USD","LU0053666078.USD","LU0889565916.HKD","IBB","LU0823416689.USD","LU2023250504.SGD","TBXU","BBH","BK4585","LU2362541513.USD","LU2237438978.USD","LU0823434740.USD","LU0882574055.USD","REGN","LU2089984988.USD","LU0114720955.EUR","LU2468319806.SGD","LU2362541273.HKD","LU2106854487.HKD","LU0289739699.SGD","BK4139","LU0109394709.USD","LU0823434583.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126045427","title":"OCUMENSION-B Completes Patient Enrollment in Phase III Trial of Dry Eye Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1126045427","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126045427?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:16","pubTimestamp":1788351373,"startTime":"0","endTime":"0","summary":"OCUMENSION-B (01477) has announced the completion of patient enrollment for its Phase III clinical trial of OT-211 (TRYPTYR® acotiamide eye drops) in the People's Republic of China, with a total of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","BK1574","IBBJ","PSYK","01477","BK1191","BMED","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664197218","title":"Political and General News Events from September 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2664197218","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664197218?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:08","pubTimestamp":1788350892,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from September 2Sept 2 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4N44U10K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","BK4534","IE0002141913.USD","BK4533","LU2112291526.USD","LU2242652126.USD","LU1983299246.USD","BK4599","LU0868494617.USD","SG9999001440.SGD","TBXU","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","IBBQ","LU0889565916.HKD","LU0122379950.USD","LU0109394709.USD","LU1023059063.AUD","LU0320765992.SGD","IBB","PBE","BK4588","BK4581","LU2089984988.USD","IE00B2B36J28.USD","BK4566","PJP","BBH","LU1057294990.SGD","LU0289739699.SGD","LU2468319806.SGD","AMGN","LU1571399168.USD","LU2242646821.SGD","IE0009355771.USD","IE00BFTCPJ56.SGD","BIB","LU1061106388.HKD","BK4585","BK4139","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819175","title":"uniQure seeks accelerated approval for Huntington’s gene therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819175?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:59","pubTimestamp":1788350375,"startTime":"0","endTime":"0","summary":"The latest update is out from uniQure ( ($QURE) ). On September 2, 2026, uniQure submitted a Biologics License Application to the U.S. Food and Dru...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/uniqure-seeks-accelerated-approval-for-huntingtons-gene-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/uniqure-seeks-accelerated-approval-for-huntingtons-gene-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNOM","LFSC","FBT","SYNB","TBXU","IBB","IBBQ","BK4588","BK4585","CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664381433","title":"Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381433","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381433?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:23","pubTimestamp":1788348209,"startTime":"0","endTime":"0","summary":"Gilead Sciences (GILD) has drawn fresh investor attention after two recent regulatory decisions. The FDA approved Bixlenvo for virologically suppressed adults with HIV, and the European Commission cleared Trodelvy plus Keytruda for certain metastatic triple-negative breast cancer patients.\nThese approvals arrive after a strong run in Gilead Sciences' stock, with a 30-day share price return of 15.14% and a year-to-date share price return of 23.29%, alongside a 36.48% 1-year total shareholder...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/is-gilead-sciences-gild-fully-valued-on-its-new-hiv-and-canc","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/is-gilead-sciences-gild-fully-valued-on-its-new-hiv-and-canc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999015978.USD","IE0002270589.USD","BK4578","LU0109394709.USD","LU0289739699.SGD","LU1585245621.USD","LU1934455194.USD","SG9999015952.SGD","SG9999015986.USD","BMED","LU2089984988.USD","BIB","IE00BZ1G4Q59.USD","LU2112291526.USD","LU1037948541.HKD","LU1061106388.HKD","BBH","TBXU","LU1934455863.HKD","MEDI","BK4532","LU1674673428.USD","LU0859254822.USD","LU0882574055.USD","BK4585","LU1066053197.SGD","GILD","IBB","BK4568","TMED","BK4139","IBBQ","IE00B7SZLL34.SGD","LU0889565916.HKD","LU0823416689.USD","LU0965509283.SGD","LU1674673691.USD","LU0114720955.EUR","LU1023059063.AUD","LU1066051498.USD","LU0965509101.SGD","LU0058720904.USD","LU1778281490.HKD","BK4566","LU0122379950.USD","LU2087621335.USD","LU2324357040.USD","IE00B19Z3581.USD","IE00B3T34201.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664081594","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664081594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664081594?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:50","pubTimestamp":1788346221,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-alumis-inc-alms-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-alumis-inc-alms-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0058720904.USD","IE0002141913.USD","LU1116320901.HKD","BK4139","GNMX","LU0265550946.USD","LU0158827948.USD","LU1057294990.SGD","LU1061106388.HKD","LU0265550359.USD","TBXU","IDNA","VERX","IE00B3T34201.USD","LU1093756325.SGD","XLV","BIB","IE00B894F039.SGD","BBH","MDT","SG9999001176.SGD","BK4533","LU1674673691.USD","LU2112291526.USD","XBI","LU0128526141.USD","LU2023251221.USD","LABU","IE00B2B36J28.USD","LU2089283258.USD","LU0314106906.USD","LU0162691827.USD","HCSG","LU1291159041.SGD","VRTX","LU1506573853.SGD","BK4588","IBBQ","IE0009355771.USD","LU2456880835.USD","BK4581","IBB","LU0106261372.USD","LU0234570918.USD","LU1778281490.HKD","IE00B19Z3B42.SGD","PBE","ALMS","LU2417539215.USD","LU0496365809.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179166528","title":"Guangdong Zhongsheng Pharmaceutical (002317.SZ) Secures NMPA Acceptance for Expanded Indication Trial of Onradivir Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=1179166528","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179166528?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:05","pubTimestamp":1788343503,"startTime":"0","endTime":"0","summary":"Guangdong Zhongsheng Pharmaceutical Co.,Ltd. (002317.SZ) has announced that its controlling subsidiary, Guangdong Zhongsheng Ruichuang Biotech Co., Ltd., recently received formal acceptance from...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","IBBQ","MDTX","BK0188","BK0239","BK0077","BMED","002317","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664589238","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2664589238","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664589238?lang=en_us&edition=fundamental","pubTime":"2026-09-02 15:40","pubTimestamp":1788334818,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (VRTX) and Cabaletta Bio (CAB...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-322?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-322?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0566484027.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","SG9999013999.USD","XLV","LU2324357040.USD","BK4581","IBBQ","LU0823416689.USD","IBB","LU1585245621.USD","LU0289739699.SGD","SG9999001176.USD","TBXU","IE00B19Z3B42.SGD","IE00BZ9MQY76.HKD","LU1674673428.USD","BK4588","XBI","IE00B2B36J28.USD","LU0079474960.USD","LU1674673691.USD","LU0029874061.USD","PBE","BK4533","LABU","IE00BJJMRZ35.SGD","LU0432979614.USD","LU2468319806.SGD","VRTX","LU1035775433.USD","HCSG","IE00B19Z9P08.USD","BIB","LU0757428866.USD","GNMX","LU2362540622.SGD","LU1093756325.SGD","IDNA","LU2417539215.USD","BK4567","BBH","LU0320765992.SGD","LU0234570918.USD","LU0109394709.USD","IE00B19Z3581.USD","BK4137","LU2456880835.USD","VERX","LU0061475181.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664689541","title":"What Does Crinetics Pharmaceuticals (CRNX) Delisting Mean After The Takeover Closed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664689541","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664689541?lang=en_us&edition=fundamental","pubTime":"2026-09-02 10:23","pubTimestamp":1788315823,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals completed its acquisition of Crinetics Pharmaceuticals (NasdaqGS:CRNX), resulting in Crinetics becoming a wholly owned subsidiary.\nCrinetics has been delisted from the Nasdaq, with leadership changes announced as part of its integration into Vertex's operations.\nThe transaction ends Crinetics' status as an independent public company and shifts its future direction under Vertex's control.\n\nFor readers tracking consolidation in biopharma and looking for more stock ideas...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crnx/crinetics-pharmaceuticals/news/what-does-crinetics-pharmaceuticals-crnx-delisting-mean-afte","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crnx/crinetics-pharmaceuticals/news/what-does-crinetics-pharmaceuticals-crnx-delisting-mean-afte","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BBH","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD","LU0320765992.SGD","LU2456880835.USD","IE0002141913.USD","LU0109394709.USD","LU1815336091.USD","LU0061475181.USD","PBE","BK4588","SGXZ57979304.SGD","IBB","LU2417539215.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU2462157665.USD","BIB","BK4533","SG9999001176.SGD","BK4585","CRNX","IE00BJT1NW94.SGD","VERX","LU1093756325.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0432979614.USD","IE0002270589.USD","LU2362540622.SGD","LU1674673428.USD","LU0256863811.USD","TBXU","BK4567","IBBQ","IDNA","BK4139","VRTX","LU1093756168.USD","LU1430594728.SGD","BK4007","GNMX","LU0417517546.SGD","BK4023","LU0234570918.USD","LU1585245621.USD","IE00B4R5TH58.HKD","LU2237438978.USD","LU1035775433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185564913","title":"Betta Pharma's Hong Kong IPO: A Profit Pioneer Faces Patent Cliffs and Pipeline Doubts","url":"https://stock-news.laohu8.com/highlight/detail?id=1185564913","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185564913?lang=en_us&edition=fundamental","pubTime":"2026-09-02 09:20","pubTimestamp":1788312055,"startTime":"0","endTime":"0","summary":"After a five-year hiatus, Betta Pharmaceuticals Co., Ltd. is once again knocking on the doors of the Hong Kong stock exchange, carrying the mantle of being the \"first domestic innovative targeted...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK0060","REDS","BK0239","300558","BK1161","IBBQ","06978","BK1574","MEDX","BK4127","KCE","IPOS","FRHC","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664743862","title":"FedEx Incheon Gateway Wins IATA CEIV Pharma Certification","url":"https://stock-news.laohu8.com/highlight/detail?id=2664743862","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664743862?lang=en_us&edition=fundamental","pubTime":"2026-09-02 08:30","pubTimestamp":1788309037,"startTime":"0","endTime":"0","summary":"FedEx Incheon Gateway wins IATA CEIV Pharma certificationFedEx’s Incheon Gateway at Incheon International Airport secured IATA CEIV Pharma certification for temperature-controlled pharmaceutical air c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL7spGmF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNMX","PBE","LU0823416689.USD","IBBQ","SHPP","LU0072461881.USD","LU2456880835.USD","SG9999013999.USD","IE0002141913.USD","LU0006061336.USD","LU2089984988.USD","BBH","LU1069344957.HKD","LU1778281490.HKD","LU2362541273.HKD","LU0058720904.USD","IE0002270589.USD","LU0061475181.USD","SG9999001176.SGD","LU0251142724.SGD","LU1267930227.SGD","VRTX","IDNA","IE00BFTCPJ56.SGD","LU1674673691.USD","LU1430594728.SGD","BIB","LU2236285917.USD","IE00B19Z9Z06.USD","TBXU","LU2237438978.USD","LU0432979614.USD","BK4585","IE00B4R5TH58.HKD","SGXZ57979304.SGD","IBB","LU0109394709.USD","FDX","LU1035775433.USD","IE00B19Z3B42.SGD","LU1093756325.SGD","IE00B19Z3581.USD","HULL","LU1585245621.USD","LU1571399168.USD","BK4533","LU0310800965.SGD","BK4139","LU0234570918.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664999869","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2664999869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664999869?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:35","pubTimestamp":1788294900,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 2.45% to $149.92 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.71% to 7,631.47 and Dow Jones Industrial Average  falling 0.79% to 52,766.88.This was the stock's second consecutive day of gains.Gilead Sciences Inc. closed 4.69% short of its 52-week high of $157.29, which the company reached on February 11th.The stock outperformed some of its competitors Tuesday, as Johnson & Johnson  rose 2.01% to $271.19, Pfizer Inc.  rose 0.32% to $28.55, and Abbott Laboratories  fell 1.30% to $108.93.Trading volume  remained 2.1 million below its 50-day average volume of 6.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 1, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU1037948541.HKD","LU1037948897.HKD","BK4566","TMED","LU0859254822.USD","LU0861579265.USD","BK4583","LU1674673428.USD","IE00B3T34201.USD","LU1839511570.USD","LU0289739699.SGD","BK4585","BMED","LU0823416689.USD","SG9999015945.SGD","GILD","LU0234570918.USD","LU1778281490.HKD","LU2468319806.SGD","SG9999015978.USD","BK4588","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU2324357040.USD","IE0002270589.USD","LU1934455277.USD","LU2357627491.SGD","LU0122379950.USD","LU0965508806.USD","LU1934455863.HKD","BK4568","IE00B19Z3581.USD","LU0320765992.SGD","IE00BZ1G4Q59.USD","LU0965509283.SGD","LU2112291526.USD","SG9999015986.USD","IBB","LU1934455194.USD","LU0114720955.EUR","LU0889565916.HKD","BK4578","IBBQ","BK4532","LU1430594728.SGD","TBXU","LU0882574055.USD","LU0965509010.AUD","LU1066051498.USD","LU1571399168.USD","LU1585245621.USD","LU1674673691.USD","IE00B7SZLL34.SGD","LU2087621335.USD","LU0109394709.USD","BK4139","IE00BSNM7G36.USD","LU0058720904.USD","BIB","LU1066053197.SGD","LU1057294990.SGD","LU0965509101.SGD","LU1061106388.HKD","MEDI","BK4550","BBH","LU1023059063.AUD","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}